This week, he will take audiences through 70 songs from his prodigious catalog across three nights at the Wallis in Beverly ...

In a report released today, Edward White from H.C. Wainwright maintained a Hold rating on Bolt Biotherapeutics (BOLT – Research Report).

A Cumbrian artist is set to release a hand-drawn, handwritten guidebook of the Lake District later this month.

From going to Fantasyland to parking in the Mickey & Friends lot, here's what to avoid at Disneyland, according to a former ...

BioAtla (BCAB – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Arthur He CFA today. The ...

THE LAST RODEO will premiere May 23, 2025. This isn’t the only exciting upcoming project at Angel Studios. They recently ...

Equities research analysts at HC Wainwright upped their FY2024 earnings per share (EPS) estimates for shares of Black Diamond ...

H.C. Wainwright lowered the firm’s price target on Curis (CRIS) to $20 from $26 and keeps a Buy rating on the shares. The firm cites dilution from this week’s registered direct offering for ...

Barinthus Biotherapeutics (NASDAQ:BRNS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a report issued on Friday,Benzinga reports. They currently have ...

Martha Wainwright has announced the dates for her 2025 UK and Ireland tour in celebration of the 20th anniversary of her self-titled debut album. The Canadian singer will kick off her tour at The ...

H.C. Wainwright initiated coverage of Vanda Pharmaceuticals (VNDA) with a buy rating, citing its negative enterprise value. Read more here.